Effectiveness and safety of follitropin alfa (Ovaleap ®) for ovarian stimulation using a GnRH antagonist protocol in real-world clinical practice: a multicenter, prospective, open, non-interventional assisted reproductive technology study.

CONCLUSION: The effectiveness and safety of OS with Ovaleap® in a GnRH antagonist protocol were extended to real-world ART clinical practice for the first time. TRIAL REGISTRATION: Registered on 22 June 2016 (retrospectively registered) at ClinicalTrials.gov (NCT02809989). PMID: 32456636 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32456636?dopt=Abstract

Source: Reproductive Biology - May 25, 2020 Category: Reproduction Medicine Authors: Sydow P, Gmeinwieser N, Pribbernow K, Keck C, Wiegratz I Tags: Reprod Biol Endocrinol Source Type: research